Harvest Fund Management Co. Ltd Makes New Investment in HCA Healthcare, Inc. (NYSE:HCA)

Harvest Fund Management Co. Ltd purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,431 shares of the company's stock, valued at approximately $841,000.

Other large investors have also made changes to their positions in the company. Brown Advisory Inc. lifted its holdings in HCA Healthcare by 53.9% in the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock valued at $1,600,000 after acquiring an additional 1,622 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in HCA Healthcare by 26.9% in the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after acquiring an additional 242 shares during the last quarter. Oppenheimer Asset Management Inc. lifted its holdings in HCA Healthcare by 2.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock valued at $1,491,000 after acquiring an additional 105 shares during the last quarter. GAMMA Investing LLC lifted its stake in HCA Healthcare by 17.6% during the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock worth $1,704,000 after purchasing an additional 737 shares in the last quarter. Finally, J.W. Cole Advisors Inc. lifted its stake in HCA Healthcare by 145.3% during the first quarter. J.W. Cole Advisors Inc. now owns 3,550 shares of the company's stock worth $1,227,000 after purchasing an additional 2,103 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded up $2.85 during midday trading on Friday, reaching $356.84. 1,369,756 shares of the company were exchanged, compared to its average volume of 1,609,565. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The stock has a fifty day simple moving average of $371.06 and a 200 day simple moving average of $346.78. The stock has a market cap of $85.84 billion, a P/E ratio of 15.00, a PEG ratio of 1.12 and a beta of 1.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The business's revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $5.50 earnings per share. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.30% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Truist Financial upped their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Bank of America cut HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective on the stock. in a research note on Wednesday, July 16th. Barclays reduced their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday. Royal Bank Of Canada set a $401.00 price objective on HCA Healthcare and gave the company an "outperform" rating in a research note on Monday. Finally, Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Nine investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $396.46.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.